The Food and Drug Administration announced plans to place a stronger warning on labels of the diabetes medication Byetta after several patients developed acute pancreatitis while taking the drug. Two patients died from the disease, which involves swelling of the pancreas, nausea and abdominal pain.The Associated Press: FDA Reports Deaths With Diabetes Drug Byetta (August 18, 2008)

In October 2007, the FDA reported 30 cases of pancreatitis in patients taking the drug, although none had died at the time of the study. Amylin agreed to put a warning label on the drug noting a possible increased risk for the ailment. On August 18, 2008, the FDA noted on its website that six more patients had developed pancreatitis since the initial report, and two had died.Forbes.com: FDA: Amylin's Byetta Killed 2 (August 18, 2008)